|
Volumn 6, Issue 5, 2015, Pages 778-787
|
Nature of the charged head group dictates the anticancer potential of lithocholic acid-tamoxifen conjugates for breast cancer therapy
|
Author keywords
[No Author keywords available]
|
Indexed keywords
4 DIMETHYLAMINOPYRIDINE;
BILE ACID CONJUGATE;
CASPASE 3;
CASPASE 9;
CHLOROACETIC ACID;
ESTROGEN RECEPTOR;
LITHOCHOLIC ACID;
PROGESTERONE RECEPTOR;
PROTEIN BCL 2;
PROTEIN BCL XL;
REACTIVE OXYGEN METABOLITE;
TAMOXIFEN;
ANISOTROPY;
ANTINEOPLASTIC ACTIVITY;
APOPTOSIS;
ARTICLE;
BREAST CANCER;
BREAST CANCER CELL LINE;
CANCER CHEMOTHERAPY;
CARBON NUCLEAR MAGNETIC RESONANCE;
CELL CYCLE;
CELL VIABILITY;
CHEMICAL INTERACTION;
CHEMICAL STRUCTURE;
DIFFERENTIAL SCANNING CALORIMETRY;
DOWN REGULATION;
DRUG CONJUGATION;
DRUG CYTOTOXICITY;
DRUG SYNTHESIS;
ELECTROSPRAY MASS SPECTROMETRY;
ESTROGEN RECEPTOR POSITIVE BREAST CANCER;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HIGH RESOLUTION MELTING ANALYSIS;
HUMAN;
HYDROPHOBICITY;
MITOCHONDRIAL MEMBRANE POTENTIAL;
POLYMERIZATION;
PRIORITY JOURNAL;
PROGESTERONE RECEPTOR POSITIVE BREAST CANCER;
PROTON NUCLEAR MAGNETIC RESONANCE;
STRUCTURE ACTIVITY RELATION;
THERMODYNAMICS;
WESTERN BLOTTING;
|
EID: 84929318698
PISSN: 20402503
EISSN: 20402511
Source Type: Journal
DOI: 10.1039/c4md00289j Document Type: Article |
Times cited : (13)
|
References (42)
|